HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Kielaite Selected Research

GYKI 47261

12/2005Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Kielaite Research Topics

Disease

1Parkinson Disease (Parkinson's Disease)
12/2005
1Dyskinesias (Dyskinesia)
12/2005

Drug/Important Bio-Agent (IBA)

1GYKI 47261IBA
12/2005
1Amantadine (Aman)FDA LinkGeneric
12/2005
1Levodopa (L Dopa)FDA LinkGeneric
12/2005
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2005
1Dizocilpine Maleate (Dizocilpine)IBA
12/2005
1Glutamate Receptors (Glutamate Receptor)IBA
12/2005
1AMPA Receptors (AMPA Receptor)IBA
12/2005
1Excitatory Amino Acid AntagonistsIBA
12/2005